Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTVneu transgenic mice

M. G. Sacco, E. Mira Catò, R. Ceruti, S. Soldati, S. Indraccolo, M. Caniatti, E. Scanziani, P. Vezzoni

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Tumor growth and metastasis are angiogenesis-dependent. The possibility of inhibiting tumor growth by interfering with the formation of new vessels has recently raised considerable interest. We previously reported that it is possible to inhibit primary tumor growth and metastasis in a transgenic model of spontaneous breast tumor, which shows many similarities to its human counterpart (including ability to metastasize) by intratumoral administration of a DNA construct carrying the murine angiostatin cDNA driven by liposomes. Here we report that it is also possible to achieve this goal by a systemic (intraperitoneal) delivery of therapeutic DNA constructs carrying genes coding for mouse and human anti-angiogenic factors which include angiostatin, endostatin and TIMP-2. These findings may be relevant to the design of therapeutic interventions in humans.

Original languageEnglish
Pages (from-to)67-70
Number of pages4
JournalGene Therapy
Volume8
Issue number1
DOIs
Publication statusPublished - 2001

Fingerprint

Angiogenesis Inducing Agents
Angiostatins
Genetic Therapy
Transgenic Mice
Breast Neoplasms
Neoplasm Metastasis
Growth
Endostatins
Tissue Inhibitor of Metalloproteinase-2
Neoplasms
DNA
Liposomes
Complementary DNA
Therapeutics
Genes

Keywords

  • Anti-angiogenesis
  • Breast adenocarcinoma
  • Gene therapy
  • Liposomes
  • Metastasis
  • Transgenic mice

ASJC Scopus subject areas

  • Genetics

Cite this

Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTVneu transgenic mice. / Sacco, M. G.; Catò, E. Mira; Ceruti, R.; Soldati, S.; Indraccolo, S.; Caniatti, M.; Scanziani, E.; Vezzoni, P.

In: Gene Therapy, Vol. 8, No. 1, 2001, p. 67-70.

Research output: Contribution to journalArticle

Sacco, M. G. ; Catò, E. Mira ; Ceruti, R. ; Soldati, S. ; Indraccolo, S. ; Caniatti, M. ; Scanziani, E. ; Vezzoni, P. / Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTVneu transgenic mice. In: Gene Therapy. 2001 ; Vol. 8, No. 1. pp. 67-70.
@article{1e2e69a56f1b4cccba4337a80ee474e8,
title = "Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTVneu transgenic mice",
abstract = "Tumor growth and metastasis are angiogenesis-dependent. The possibility of inhibiting tumor growth by interfering with the formation of new vessels has recently raised considerable interest. We previously reported that it is possible to inhibit primary tumor growth and metastasis in a transgenic model of spontaneous breast tumor, which shows many similarities to its human counterpart (including ability to metastasize) by intratumoral administration of a DNA construct carrying the murine angiostatin cDNA driven by liposomes. Here we report that it is also possible to achieve this goal by a systemic (intraperitoneal) delivery of therapeutic DNA constructs carrying genes coding for mouse and human anti-angiogenic factors which include angiostatin, endostatin and TIMP-2. These findings may be relevant to the design of therapeutic interventions in humans.",
keywords = "Anti-angiogenesis, Breast adenocarcinoma, Gene therapy, Liposomes, Metastasis, Transgenic mice",
author = "Sacco, {M. G.} and Cat{\`o}, {E. Mira} and R. Ceruti and S. Soldati and S. Indraccolo and M. Caniatti and E. Scanziani and P. Vezzoni",
year = "2001",
doi = "10.1038/sj.gt.3301358",
language = "English",
volume = "8",
pages = "67--70",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTVneu transgenic mice

AU - Sacco, M. G.

AU - Catò, E. Mira

AU - Ceruti, R.

AU - Soldati, S.

AU - Indraccolo, S.

AU - Caniatti, M.

AU - Scanziani, E.

AU - Vezzoni, P.

PY - 2001

Y1 - 2001

N2 - Tumor growth and metastasis are angiogenesis-dependent. The possibility of inhibiting tumor growth by interfering with the formation of new vessels has recently raised considerable interest. We previously reported that it is possible to inhibit primary tumor growth and metastasis in a transgenic model of spontaneous breast tumor, which shows many similarities to its human counterpart (including ability to metastasize) by intratumoral administration of a DNA construct carrying the murine angiostatin cDNA driven by liposomes. Here we report that it is also possible to achieve this goal by a systemic (intraperitoneal) delivery of therapeutic DNA constructs carrying genes coding for mouse and human anti-angiogenic factors which include angiostatin, endostatin and TIMP-2. These findings may be relevant to the design of therapeutic interventions in humans.

AB - Tumor growth and metastasis are angiogenesis-dependent. The possibility of inhibiting tumor growth by interfering with the formation of new vessels has recently raised considerable interest. We previously reported that it is possible to inhibit primary tumor growth and metastasis in a transgenic model of spontaneous breast tumor, which shows many similarities to its human counterpart (including ability to metastasize) by intratumoral administration of a DNA construct carrying the murine angiostatin cDNA driven by liposomes. Here we report that it is also possible to achieve this goal by a systemic (intraperitoneal) delivery of therapeutic DNA constructs carrying genes coding for mouse and human anti-angiogenic factors which include angiostatin, endostatin and TIMP-2. These findings may be relevant to the design of therapeutic interventions in humans.

KW - Anti-angiogenesis

KW - Breast adenocarcinoma

KW - Gene therapy

KW - Liposomes

KW - Metastasis

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=0035134335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035134335&partnerID=8YFLogxK

U2 - 10.1038/sj.gt.3301358

DO - 10.1038/sj.gt.3301358

M3 - Article

C2 - 11402303

AN - SCOPUS:0035134335

VL - 8

SP - 67

EP - 70

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 1

ER -